"Evaluating cost-effectiveness of allogeneic T-cell immunotherapy based on a bioprocess economic model" by Negin Razavilar

Faculty Works of Negin Razavilar

Follow Contact

Other

Evaluating cost-effectiveness of allogeneic T-cell immunotherapy based on a bioprocess economic model

(2017)

Negin Razavilar, Kettering University
Klemens Wallner, University of Alberta

Link

Disciplines

Life Sciences,
Biotechnology,
Statistics and Probability,
Statistical Models and
Data Science

Publication Date

2017

Comments

Publication Date: 2017/4/2

Conference: Abstracts of Papers of the American Chemical Society

Volume: 253

Publisher: AMER CHEMICAL SOC

Citation Information

Negin Razavilar and Klemens Wallner. "Evaluating cost-effectiveness of allogeneic T-cell immunotherapy based on a bioprocess economic model" (2017)
Available at: http://works.bepress.com/negin-razavilar/11/